Targeted Bleeding Management Reduces the Requirements for Blood Component Therapy in Lung Transplant Recipients

    loading  Checking for direct PDF access through Ovid

Abstract

(Abstracted from J Cardiothorac Vasc Anesth, 31:426–433, 2017)

High rates of bleeding and allogeneic blood transfusions to treat bleeding are associated with adverse outcomes in bilateral sequential lung-transplant patients. The aim of this study was to determine if point-of-care coagulation testing could minimize unnecessary transfusion in lung-transplant patients.

Related Topics

    loading  Loading Related Articles